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Objectives. To demonstrate the feasibility of the prenatal diagnosis of partial androgen insensitivity syndrome by 3D-4D ultrasound.
Methods. To report prenatal diagnosis of partial androgen insensitivity syndrome at 32nd week of gestation by 3D-4D ultrasound
in a fetus with a 46XY karyotype, testing negative to the mutation analysis of SRY gene and the 5𝛼-reductase 2 gene (SRD5A2).
Results. 3D-4D surface rendering allows the detection of external and internal genital malformations and can address the prenatal
diagnosis of PAIS and can exclude associated complications. Conclusions. Prenatal diagnosis of PAIS allows an adequate parental
counseling and an early optimal management of the condition, not only for the psychological and social reflections but also for the
avoidance of complications and postnatal morbidity due to misdiagnosis or delays in the treatment of the genital ambiguity.
Androgen insensitivity syndrome (AIS;MIMno. 300068)
represents the most common identifiable cause of male
pseudohermaphroditism, accounting for asmany as 1 : 20.000
births [1]. The disease is transmitted in an X-linked recessive
fashion and is featured by an abnormal development of both
internal and external genital structures in 46 XY individuals.
The associated phenotypes range from male infertility or
undervirilization (partial androgen insensitivity syndrome
(PAIS) (grade 1)), to completely normal female external geni-
talia (complete androgen insensitivity syndrome (CAIS)
(grade 6/7)), in rank of increasing severity of androgens resis-
tance [2]. PAIS is diagnosed when gonadotropins and testos-
terone are normal, but the physiological androgen response
in target tissues is absent or decreased, due tomutations in the
androgen receptor (AR) gene, located inXq12 [1, 3].We report
a case of a 35-year-old healthy pregnantwoman, primigravida
at the 32ndweek of gestation, that was referred to our prenatal
diagnosis unit for a mild polyhydramnios. Chorionic villus
sampling (CVS) had been previously performed for maternal
age at the 11th week, revealing a normal 46 XY karyotype.
Routine prenatal ultrasonographic examination performed
in another center at the 20th week and 30th week of gestation
revealed a normal fetus with no mention of the external
genitalia. We performed 2D and 4D ultrasonographic (US)
examinations using Voluson E8 (GE Healthcare, Milwaukee,
WI, USA) with a volumetric 4–8MHz transducer, observing
a normal amount of amniotic fluid and revealing the presence
of female/ambiguous genitalia in an otherwise normal fetal
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Figure 1: (a) 4D surface rendering female/ambiguous external genitalia; (b) female genitals with oedematous labia majora and mild
clitoromegaly; (c) perineal vulvovaginoplasty, clitoroplasty, and gonadectomy.
anatomy. The 4D surface rendering showed typical female
genitalia with mildly oedematous labia majora and clitor-
omegaly (Figure 1(a)). The fetal uterus was not visualized
with both conventional 2D US and 3D US with VCI software
in A-plane.
To clarify the discrepancy between the male karyotype
and the female genital phenotype, an amniocentesis was
performed and the fetal DNA extracted from the cultured
amniocytes was tested by direct sequencing for mutations
in the SRY gene and in the 5𝛼-reductase 2 gene (SRD5A2)
to exclude other causes of hermaphroditism or pseudo-
hermaphroditism. Both analyses did not reveal anymutation.
Therefore, the presence of female external genitalia with-
out the uterus, in association with normal SRY and SRD5A2
genes, led us to the diagnostic hypothesis of (complete
or partial androgen insensitivity syndrome) (CAIS/PAIS),
that was tested through the sequence analysis of the AR
gene which did not show any mutation. A multidisciplinary
counseling session was scheduled with the parents to address
the issue of the female sex assignment at birth. Delivery
was at the 39th gestational week. The female external gen-
italia with clitoromegaly at birth are shown in Figure 1(b);
moreover, the clinical inspection of the external genitalia
revealed palpable gonads bilaterally in the labioscrotal folds.
The hormonal blood profile detected normal concentra-
tions of testosterone (79 ng/dL) and androgens (DHEAS
7.5mcgr/mL, androstenedione 209.4 ng/dL) for age and male
sex and also after hCG test (testosterone 146 ng/dL, DHEAS
7.5mcgr/mL, and androstenedione 126.4 ng/dL). Urethro-
cystoscopy showed the presence of a low urogenital sinus,
corresponding to the 4th degree of PAIS, defined as severely
limited masculinization with phallic structure intermediate
between clitoris and penis and urogenital sinus with perineal
orifice and labioscrotal folds [2]. Videolaparoscopy revealed
the complete absence of internal female genital structures in
the Douglas cavity and the presence of internal spermatic
blood vessels and deferent ducts ending bilaterally into the
peritoneal vaginal duct with an opened internal orifice. In
order to achieve the complete female phenotype, the newborn
underwent surgical treatment of perineal vulvovaginoplasty,
clitoroplasty, and gonadectomy (Figure 1(c)). Pathological
examination demonstrated that the gonads were represented
by normal testicles with normal epididymis and deferent
ducts.
In the present report, we show how the prenatal diagnosis
of PAIS allows an adequate parental counseling and an opti-
mal management of the condition, not only for the relevant
psychological and social implications of an early diagnosis
but also for the reduction of the chance of complications
and postnatal morbidity due to misdiagnosis or delays in the
treatment of the genital ambiguity.
The contribution of US in prenatal sex determination is
well known, and its role in detecting sexual differentiation
disorders has been previously established [4]. In addition, the
limitations of standard 2D fetal US [5] have been overcome
by the advent of 3D-4D US that has allowed the study of
the anatomy of the internal genitalia [6, 7]. In particular, the
exclusion of the presence of the fetal uterus at weeks 32–34
of pregnancy by 3D VCI in A-plane has been crucial for the
prenatal diagnosis of the present case.
The mainstay of the diagnosis of PAIS is the presence
of a 46 XY karyotype, the determination of the normality
(baseline or after hCG stimulation) of testosterone and
dihydrotestosterone levels (in order to exclude defects in
testosterone biosynthesis or 5𝛼-reductase 2 deficiency), and
the confirmation of the diagnosis through the identification
of a molecular defect in AR gene. In our case, direct
sequencing of all of the 8 exons of the AR gene did not detect
anymutation, consistentwith themutation rate of 28% to 73%
for the incomplete, milder phenotypes [1].
In conclusion, 3D-4D US and surface rendering have
demonstrated their power in the detection of external and
internal genital malformations, and in association with the
molecular exclusion of the main causes of hermaphroditism
and pseudohermaphroditism they have addressed the pre-
natal diagnosis of PAIS, although it is not confirmed by the
finding of the mutation in the AR gene. Also the ability to
exclude associated complications (i.e., urological) has given
the possibility of a reassuring prenatal counseling session
about the excellent prognosis of the condition, contributing
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to improve the quality of life and health for both the child
and the parents.
References
[1] S. F. Ahmed, A. Cheng, L. Dovey et al., “Phenotypic features,
androgen receptor binding, and mutational analysis in 278
clinical cases reported as androgen insensitivity syndrome,”
Journal of Clinical Endocrinology and Metabolism, vol. 85, no.
2, pp. 658–665, 2000.
[2] C. A. Quigley, A. de Bellis, K. B. Marschke, M. K. El-Awady, E.
M.Wilson, and F. S. French, “Androgen receptor defects: histor-
ical, clinical, and molecular perspectives,” Endocrine Reviews,
vol. 16, no. 3, pp. 271–321, 1995.
[3] S. Bianca, A. Cataliotti, G. Bartoloni et al., “Prenatal diagnosis of
androgen insensitivity syndrome,” Fetal Diagnosis andTherapy,
vol. 26, no. 3, pp. 167–169, 2009.
[4] V. Mazza, I. Di Monte, M. Pati et al., “Sonographic biometrical
range of external genitalia differentiation in the first trimester
of pregnancy: analysis of 2593 cases,” Prenatal Diagnosis, vol.
24, no. 9, pp. 677–684, 2004.
[5] D. Soriano, S. Lipitz, D. S. Seidman, R. Maymon, S. Mashiach,
and R. Achiron, “Development of the fetal uterus between 19
and 38 weeks of gestation: in-utero ultrasonographic measure-
ments,” Human Reproduction, vol. 14, no. 1, pp. 215–218, 1999.
[6] C. S. Naylor, D. E. Carlson, T. Santulli, and L. D. Platt, “Use
of three-dimensional ultrasonography for prenatal diagnosis of
ambiguous genitalia,” Journal of Ultrasound inMedicine, vol. 20,
no. 12, pp. 1365–1367, 2001.
[7] L. S. Onderog˘lu, D. Bas¸aran, O. Ozyu¨ncu¨ et al., “Prenatal diag-
nosis of partial androgen insensitivity syndrome by means
of a 4-D ultrasound technique,” Journal of Obstetrics and
Gynaecology Canada, vol. 34, no. 1, p. 9, 2012.
